Breaks Categories: News

ThursdayJan 13, 2022 3:32 pm

CannabisNewsBreaks – Alternative Products Expo Announces March Debut with Thousands of Products Under One Roof

The first Alternative Products Expo of 2022 will be held March 11–13, 2022, at the Broward County Convention Center in Ft. Lauderdale, Florida. Formerly known as the USA CBD Expo, the Alternative Products Expo features more than 50 expert speakers and insightful presentations, as well as more than 300 vendors providing a look at thousands of alternative products. Presented by 3Chi, the nation’s largest CBN and Delta-8 distributor, the upcoming expo builds on the foundation established by the USA CBD Expo, which had grown to become North America’s largest CBD-focused event. The new event has added a more comprehensive overview…

Continue Reading

TuesdayJan 11, 2022 2:10 pm

CannabisNewsBreaks – AmeriCann (ACAN) Achieves 225% YOY Revenue Growth

AmeriCann (OTCQB: ACAN), a cannabis company that develops state-of-the-art cultivation, product manufacturing and distribution facilities, today announced that the company’s year-over-year revenue growth exceeded 225% from the calendar year of 2020 to 2021. AmeriCann attributes the increase in financial performance to greater revenue received from products produced and manufactured at the company's initial development at its Massachusetts Cannabis Center in Freetown, Massachusetts. Among the highlights for the 12 months ended December 2021, AmeriCann reported an increase of 225% in operating revenue for the 12 months ended December 2021 as compared to the prior year. In addition, the company achieved positive…

Continue Reading

TuesdayJan 11, 2022 11:44 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Completion of First Cannabis Extraction Through New Facility

Flora Growth’s (NASDAQ: FLGC) wholly owned subsidiary, Cosechemos, has produced the first batch of crude oil through its newly constructed extraction facility. FLGC, a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, made the announcement, adding that the 10,500-square-foot plant, which has an annual capacity to produce 15,000 L of distillate, is also taking steps to become EU-GMP certified. Full certification will allow the company to export medical-grade cannabis derivatives to international markets. The plant is Flora Growth’s primary processing location and facilitates the drying and processing of the company’s all-outdoor cultivated flower into finished, packaged dry…

Continue Reading

MondayJan 10, 2022 2:15 pm

CannabisNewsBreaks – Use of Cannabis in PTSD Treatment of Navy Seals Discussed by Leading Psychologist

Harvard-trained forensic psychologist Dr. Kara Coe has released an update discussing her innovative use of cannabis as she works Navy SEALs dealing with post-traumatic stress disorder (“PTSD”). Coe has established a reputation for being one of the most successful interrogators in military history, and her well-respected PTSD treatment practice is located in Virginia Beach, home to the largest military bases in the world. According to the announcement, Coe treats almost 30 active-duty SEALs in weekly, no-cost group therapy meetings. She is known for using cannabis in her treatment efforts that, while unorthodox, have produced life-changing results. Coe points to significant…

Continue Reading

ThursdayJan 06, 2022 2:23 pm

CannabisNewsBreaks – VPR Brands LP (VPRB) Announces Settlement of Second Patent Infringement Case

VPR Brands (OTC: VPRB) is a market leader and pioneer in electronic cigarettes and vaporizers for nicotine, cannabis and cannabidiol (“CBD”). The company owns intellectual property, which is one of the original patents filed for electronic cigarette technology. Dating to 2009, the patent includes independent claims covering electronic cigarette products containing an electric airflow sensor, including a sensor comprised of a diaphragm microphone. The technology, covered under electronic cigarette utility patent US 8,205,622, includes an airflow sensor that turns the battery on and off and covers most auto-draw, button less e-cigarettes, cig-a-likes, pod devices and vaporizers. According to the update,…

Continue Reading

ThursdayJan 06, 2022 11:15 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Strategic Advisory Board Appointment

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced the appointment of accomplished business leader and cannabis industry expert Tim Leslie as the chairman of its newly formed advisory board. Establishment of the advisory board comes as Flora continues to develop its corporate structure to include a robust roster of human capital. Leslie’s appointment aligns with the company’s goal of working with the industry’s best leaders to provide strategic counsel on matters that will fuel its growth. “We are pleased and honored to have Tim join us as the first chairman of…

Continue Reading

WednesdayJan 05, 2022 12:51 pm

CannabisNewsBreaks – The Honeybee Collective Breaks Record to Raise $107K in First Funding Round

The Honeybee Collective, an employee-owned, community-driven, sustainable cannabis startup launching in February 2022, today announced that it raised $107,000, a first-round maximum, in just four days. According to the update, the campaign broke crowdfunding platform Mainvest's 48-hour funding record, raising $80,000. The company’s campaign will reopen on Jan. 10, 2022, with a $250,000 overall fundraising goal. “We knew our community would support The Honeybee Collective’s mission because we built our brand in direct conversation with them, but we never could have predicted how that support would translate into dollars so quickly,” said Erin Parkins, co-founder and managing partner, Marketing and…

Continue Reading

TuesdayJan 04, 2022 12:18 pm

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Foray into Mexico, Showcased in Latest Episode of ‘Bell2Bell’ Podcast

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products, today announced that its Mind Naturals skincare brand has launched sales through Walmart.com and Coppel, a nationwide department store in Mexico. According to the update, the launch includes 12 products from the Mind Naturals portfolio, initially via e-commerce with subsequent plans to sell in brick-and-mortar retail locations. “We are excited to begin bringing high-quality, sustainable CBD skincare products to Mexico,” said Luis Merchan, CEO of Flora Growth Corp. “This agreement represents our first foray into the Mexican market and furthers our global foothold as a leader in…

Continue Reading

ThursdayDec 30, 2021 10:37 am

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at Tribe Public’s Webinar Event

InMed Pharmaceuticals (NASDAQ: INM), a leader in the development, manufacturing and commercialization of rare cannabinoids, today announced that its CEO Eric A. Adams, SVP and General Manager of BayMedica, Shane Johnson, and VP of Commercial Operations Chris Meiering will present at Tribe Public’s upcoming webinar presentation and Q&A event. The event, titled “Addressing the Increasing Demand for Rare Cannabinoids,” is slated to begin at 8 a.m. Pacific/11.a.m. Eastern on Jan. 6, 2022. Interested parties should visit https://cnw.fm/rKO43 to register to join the complimentary, ZOOM webinar-based event. Once registered, participants may begin forwarding their questions for InMed and BayMedica’s management to…

Continue Reading

WednesdayDec 29, 2021 1:06 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Approval from Independent Review Board for DehydraTECH-CBD Human Clinical Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has received Independent Review Board ("IRB") approval for its planned DehydraTECH-CBD human hypertension study HYPER-H21-4; the approval was received earlier than anticipated. The study is designed to "de-risk" outcomes prior to the company’s planned entry into regulatory pathways for the use of DehydraTECH-CBD to treat hypertension and perhaps other forms of cardiovascular disease. The six-week study, which is entirely funded through the existing cash resources, is planned to include 60 volunteers, aged 45 to 70, using three 150 mg doses of DehydraTECH-CBD daily for the duration of the study. Dosing…

Continue Reading